Regular monitoring of inflammatory markers, disease activity scores, and functional status remains essential regardless of concurrent GLP-1 use
Why GLP-1 Medications Are Reshaping Weight Loss These medications were originally developed for patients with type 2 diabetes, but their effects on appetite regulation, insulin sensitivity and inflammation quickly pushed them into the spotlight for weight loss
Neural activation and POMC expressions were observed in two different neuronal populations
Sustainable eating habits, adequate protein intake, and nutrient-dense foods can help support long-term weight maintenance after stopping medication.
Consider switching to a non-oral contraceptive method (such as an IUD, patch, or implant), or use an additional barrier method (such as condoms) for at least 4 weeks after starting semaglutide and for at least 4 weeks after each dose increase